SWOG clinical trial number
SWOG-7430

5-Fluorouracil and Adriamycin in the Treatment of Incurable Hepatoma

Closed
Phase
II
Abbreviated Title
5-Fluorouracil and Adriamycin in the Treatment of Incurable Hepatoma
Activated
11/05/1974
Closed
06/11/1976

Research committees

Gastrointestinal Cancer

Publication Information Expand/Collapse

1977

Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.

LH Baker;JH Saiki;SE Jones;JS Hewlett;RW Brownlee;RL Stephens;VK Vaitkevicius Cancer Treat Rep 61:1595-97

1976

5-fluorouracil and adriamycin therapy for hepatoma.

LH Baker;VK Vaitkevicius AACR 17:215 #859

Other Clinical Trials

SWOG Clinical Trial Number
S1922

Randomized Phase II Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma

Research Committee(s)
Gastrointestinal Cancer
Activated
12/16/2019
Accrual
1%
Open
Phase
II
SWOG Clinical Trial Number
S1815
SWOG Clinical Trial Number
S1613